In an attempt to improve postoperative pain management an intravenous infusion of pethidine was designed to provide stable therapeutic blood concentrations. Ten female patients undergoing elective abdominal hysterectomy were studied. After commencement of the infusion, blood pethidine concentrations increased rapidly and exceeded 0.46 p,g/ml after four hours. The mean steady-state concentration of 0.67 p,g/ml was reached by twenty-four hours. This infusion regimen resulted in the abolition of severe pain after three hours and analgesia continued for the duration of the two day study. Significant blood concentrations of the metabolite norpethidine were found although clinically no toxic effects were observed. Side effects of pethidine were infrequent. Controlled continuous intravenous infusion of pethidine produced stable blood concentrations and provided excellent pain control. • F.F.A.R.A.C.S .. Senior Anaesthetic Registrar. t M.Sc., Hospital Scientist.
INTRODUCTION
Pain is commonly under-treated (Kamel and Geddes 1978 , Keeri-Szanto and Heaman 1972 , Leading Article 1976 , Marks and Saohar 1973 . Despite the ready availability of potent analgesic drugs, patients still rank postoperative pain high on their list of unpleasant peri-operative memories. Narcotic analgesics for postoperative pain are traditionally administered by intermittent intramuscular injection. Doses and dose intervals are empirically derived and based on patient requirements but are often tempered by the attendants' inconsistent interpretation of analgesic efficacy and addiction potential (Lasagna 1964) .
Single intramuscular injections of pethidine produce blood concentrations which increase to a maximum within one hour and decrease in an exponential manner. However, rates of absorption of pethidine after intramuscular injections vary and result in a wide range of maximum concentrations and considerable variation in the times at which these occur (Chan, Kendall and Mitchard 1974 , Chan et al. 1975 , Hartvig et al. 1977 , Mat'her et al. 1975 , Shih, Robinson and Au 1976 , Stambaugh and Wainer 1974 , Stambaugh et al. 1976 . Little is known about therapeutic blood levels of pethidine although plasma concentrations of 0.2 p,g/ml were analgesic in 8 young women following abdominal tuballigations (Shih et al. 1976) .
Poor control of postoperative pain may result from inadequate and fluctuating blood drug concentrations following intramuscular injections and may be compounded by marked variability in absorotion rates. If there is a minimum analgesic blood concentration for the control of postoperative pain as suggested by Shih et al. (1976) , then the success of treatment may rest on maintaining blood levels above this concentration.
Pharmacokinetic t'heory predicts that continuous intravenous infusion of drugs produces steady-state blood concentrations in about six half-lives. For pethidine this will be around twenty-four hours. In the present study a computer simulation programme (Iben and Anderson 1975) supplied with pharmacokinetic data derived from surgical patients (Mather et al. 1975 ) was used to design an intravenous infusion regimen in which the analgesic level reported by Shih et al. ( 1976) would. be exceeded within half an hour of commencIng the infusion, and 80% of the ultimate steady-state achieved within six hours.
The objectives of the present study were to describe the blood concentrations of pethidine which occur during intravenous infusion over a period of two days, to evaluate the clinical efficacy of the infusion regimen in controlling postoperative pain and to evaluate simple indices which may enable prediction of individual dosage requirements.
MATERIALS AND METHODS
The subjects of this study were ten female patients who were free of kidney and liver disease and scheduled for an abdominal hysterectomy. Their informed consent was obtained. Ages ranged from 29 to 67 years and body weights varied from 48 to 81 kg (Table I) . Lean tissue mass was calculated according to Crankshaw and Allt-Graham (1978) and ranged from 38 to 46 kg. A distal vein in the right arm was cannulated for drug administration. The left subclavian vein was cannulated via the left antecubital fossa and fitted with a double three-way stopcock for serial blood sampling. Patients were premedicated with diazepam (7.5 mg) injected intravenously over several minutes, one hour prior to surgery. Anaesthesia consisted of atropine, thiopentone, nitrous oxide/oxygen, muscle relaxants, halothane and controlled resoiration.
Postoperatively a svringe pump* was used to infuse pethidine HCI (1.9 mg/ml) into the side arm of the peripheral intravenous cannula. A loading dose of 1.0 mg/min for 45 minutes was followed by 0.53 mg/min for 28 minutes. A maintenance rate of 0.4 mg/min (24 mg/ hr) was used for the remainder of the thirty-two hour studv period. Hence patients received an average of 100 mg/4 hr during the treatment period.
Samples of subclavian venous blood were taken at intervals of 5 minutes up to 45 minutes, 15 minutes to 2 hours. 30 minutes to 4 hours and then hourly to 8 hours on the day of operation. Patients were left undisturbed • Braun-Melsungen pump model: UNIT A 1. overnight and sampling resumed the following morning (twenty-four hours after the infusion had commenced) and continued thereafter at hourly intervals for a further eight hours.
Blood samples (exactly 1.0 ml) were added to glass tubes containing heparin (25 U/25 1'1) and lignocaine (0.5 f'g/50 1'1) Internal standard. Pethidine and norpethidine were determined by a modification to the basic method of Mather and Tucker (1974) , using a gas chromatograph** fitted with dual nitrogen-phosphorus sensitive detectors and using an oven temperature of 210°C with nitrogen carrier gas.
An independent trained observer (Pain Clinic Sister) made hourly pain and comfort assessments by brief interview during the two eight hour sampling periods. Pain was assessed by asking the patient 'Do you have pain now?'. If the response was 'no', a score of 0 was recorded, but if the answer was 'yes', then two further questions were asked. The question 'Do you think you need more medicine for the pain?' was designed to indicate the severity of the pain. An answer of 'no' suggested the patient had moderate pain but was able to cope with it and a score of 1 was recorded. If the patient replied 'yes', then severe pain was indicated and a score of 2 was recorded. The second question, 'Tell me about the ~ite and nature of your pain' was asked to conf~rm that the pain was originating from the surgical site.
Since pain as such cannot be estimated by observation, a comfort score was designed which would indicate the general clinical state of the patient. The Pain Clinic Sister obs.erved the patient and recorded a score, usually Without the knowledge of the patient and always without disturbing her. A score of 0 corresponded to 'apparently comfortableperhaps sleeping', a score of 1 indicated some apprehension (moderately disturbed) and a value of 2 represented a markedly disturbed patient apparently in severe pain.
Means and standard deviations are reported for all data which can be classed as 'interval' or 'ratio' (Siegel 1956) . Intermediate or mean pain scores can only be implied because pain scores are 'ordinal' data. Medians were therefore used as the indication of central tendency for pain scores.
Statistical Package for the Social Sciences ** Hewlett Packard gas chromatograph model 5700.
Anaesthesia alld Intensive Care, Vol. VII, No. I, Februar,l ', 1979 (SPSS) was used on a digital computer* to analyze for differences in pain scores as a function of time or blood concentration, using the non-parametric subroutines (SPSS version 7.01 1977, Nie et al. 1975) . Non-parametric tests (Kruskal-Wallis, Mann-Whitney, Kolmogorov-Smirnov and the Median test) were used exclusively because data of this type are not distributed normally (Fuccella et al. 1977) and only 'ordinal' data were involved (Siegel 1956) .
RESULTS

Blood pethidine and norpethidine concentrations
Mean blood concentrations of pethidine for the ten patients are shown in Figure 1 . Pethidine concentrations increased rapidly over the first 1-2 hours and exceeded 0.2 ftg/ml wi~hin thirty minutes ( Figure 1) . A consistent but small decrease in concentration was noted about three hours after infusions had commenced and was associated with a change in pump speed. However, blood concentrations following the transient fall increased quickly to reach 75% of the final mean steady-state ccncentration (0.67 ftg/ml, Table 1 ) by six hours.
Low concentrations of the metabolite norpethidine were detected in blood as early as 1 t hours after the commencement of the infusion. Concentrations of norpethidine increased slowly in a linear fashion over the remainder of the study reaching a mean (-+-S.D.) concentration of 0.42 ± 0.16 ftg/ml at the conclusion of the infusion. Median pain scores were moderate for the first four hours of infusion and fell to 0 (pain free) after a therapeutic blood concentration of 0.46 ",g/ml was reached. Median pain scores of 0 were recorded for the remainder of the thirty-two hour infusion. Pain and comfort estimation Median pain scores derived from questioning patients are shown in Figure 1 . Scores of 1 (moderate pain) were evident for four hours. After four hours of infusion median pain scores were 0 (no pain) and remained so until the end of the thirty-two hour period. The distribution of scores of 1 and 2 is given in Figure 2 . Severe pain was experienced by 20% of patients over the first two hours and by 40% at three hours. Severe pain was not experienced by any patient after three hours while moderate pain was recorded on about 20% of all observations during the remainder of the study (Figure 2 ). Non-parametric analysis of variance (median test for multiple samples p < 0.007, Kruskal-Wallis test p < 0.002) indicated significant differences in pain scores over the thirty-two hours. Further analysis on hourly observations showed no difference in pain scores for any specific times, but did reveal a very significant difference between pain scores grouped over the first four hours when compared with scores taken between five and thirty-two hours (Median test, p < 0.0001; Kruskal-Wallis, p < 0.0001; Kolmogorov-Smirnov two sample test, p < 0.0001).
The relationship between median pain score and blood pethidine concentrations is shown in Figure 3 . The marked decrease in median pain score corresponded to a pethidine blood concentration of approximately 0.45 ",g/ml. Median comfort scores estimated by the trained observer were 0 for the whole period, although scores of 1 were recorded on 7 out of 170 (4%) observations during the complete study and on only lout of 120 (0.8%) occasions after five hours.
Blood pethidine concentrations corresponding to particular pain scores are presented in Figure 4 . The mean blood concentrations associated with each of the pain scores was: o = 0.59 ± 0.17 ",g/ml, 1 = 0.51 ± 0.19 ,...g/ml and 2 = 0.33 -+-0.09 ,...g/ml. The statistical significance between these groups is: scores 0 and 2, p < 0.0001, scores 0 and 1, p < 0.02 and scores 1 and 2, p < 0.01 using both the Student's "t" and Mann-Whitney tests.
Complete analgesia on the second day could have been due to the efficacy of the narcotic or a lack of stimulus from the incision site. After cessation of the pethidine infusion all patients requested further analgesics at a mean time of five hours indicating that the former was the case. 3.5 3 4.7 5 5 4 5 6.5 2.5 10 5 2 10
Time taken before further narcotic was requested following termination of the infusion. Intramuscular narcotic was administered to all but one patient (No. 5) who received oral codeine phosphate. observed during the first three hours of infusion. There was considerable overlap between the ranges of blood concentrations associated with pain scores of 0 and I. Significant differences could be demonstrated between all groups (0-1, p = 0.015; 1-2, P = 0.008; 0-2, P < 0.001; Mann-Whitney U test). Bars and horizontal brackets denote means and standard deviations.
Side effects of pethidine were infrequent throughout the study. Mean systolic blood pressures were not significantly altered by the infusion (Table 3 ). The majority of patients had amnesia for the events of the day of operation. Patients who were rational at the time had only vague recall of procedures and interviews. Nine of the ten patients remained alert and rational. One patient was consistently drowsy.
Steady-state blood concentrations of pethidine showed a twofold variation among patients (0.45 -0.82 ftg/ml, Table O . 
DISCUSSION
Intravenous infusions of pethidine avoid the variability in absorption rate seen after intramuscular injections (Mather et al. 1975) and produce stable blood concentrations (Figure 1 ). Using this infusion technique, concentrations increased rapidly and exceeded the analgesic level of 0.2 "giml reported by Shih et al. (1976) within thirty minutes. However it is clear from Figures 1 and 2 that this level was not sufficient to relieve severe or moderate pain in the majority of patients in this study. Over 60% of all patients experienced either severe or moderate pain for the first four hours of the infusion despite the fact that the blood pethidine concentrations were 50-100% in excess of the suggested therapeutic concentration (Figures 1, 2 and 3) . After the blood concentrations had reached 0.46 "giml (occurring after four to five hours) severe pain was not experienced by any patient until about five hours after the thirty-two hour infusion had ceased. Hence, it would appear that a minimum therapeutic blood concentration of pethidine does exist for the relief of severe pain and it is in the vicinity of 0.46 "giml ( Figure 3) . Moderate pain was associated with a range of blood concentrations (x _ 0.51 "giml, S.D. = 0.19, n = 45, Figure 4 ). About 20% of all scores recorded on the second day were for moderate pain with 80% of them coming from three patients. The increase in the incidence of severe pain over the first three hours (Figure 2) is probably due to emergence from the effects of general anaesthesia before the pethidine concentrations had reached adequate levels.
Despite acknowledged problems with the measurement of pain using bioassay techniques, there are many examples of its usefulness, especially in comparison of regimens (Fuccella et al. 1977 , Beaver et al. 1977 , Kay 1978 . The pain scoring system employed in the present study was designed to distinguish between the presence or absence of pain, and if it was present, whether the patient was able to cope with it. The questions required a simple 'yes' or 'no' answer. Therefore patients did not have to move to point at numbers or mark visual analogue scales. A visual analogue scale was used in a preliminary investigation but there was a tendency for patients to be confused in its interpretation particularly while still under the influence of general anaesthetic agents .
Although the system used here may be less sensitive to small changes in pain than other Anaesthesia and Intensjl'e Care, VoL Vll. 1,\'0, 1. Februar) '. 1979 systems with more gradations, there was no ambiguity regarding the results. Losses in sensitivity were compensated for by increases in precision. The ability of the patient to distinguish between the various levels of pain is highlighted by an additional patient illustrated in Figure 7 . Sudden onset of severe pain in a previously analgesic patient necessitated closer examination by her gynaecologist. The blood concentration of pethidine was sufficient to suppress baseline pain completely until a haematoma caused additional pain. Patients can be made stable and pain free during the infusion, hence any sudden increase in pain necessitates investigation. (00) of an additional patient who developed a wound haematoma. After an uneventful first day and night she began the second post-operative sampling period with a blood concentration of 0.65 ",g/ml and complete analgesia. Between the second and third hours a sudden onset of wound pain occurred which caused her pain score to increase from 0 to 2 over a two hour period. A large haematoma in the operative site was diagnosed by her gynaecologist. She continued to have severe pain for over two hours. At this point (arrow) the blood concentration was 0.70 ",g/ml, and it was considered safe to double the infusion rate of pethidine in an attempt to control her pain. The concentration of pethidine increased markedly over the following It hours to 1. 13 ",g/ml accompanied by a corresponding reduction in pain score from 2 to O.
NOTE:
(i) The infusion did not mask additional pain.
(ii) The additional pain was controlled by an increased concentration and (iii) No side effects were evident when the blood concentration reached 1. 13 ",gl m!.
Blood concentrations decreased rapidly when the pump was switched off and became sub-therapeutic within as little as 2.5 hours ( Table 2 ). The incidence of side effects was extremely low during the study even though relatively high blood concentrations were sometimes reached (0.8 -1.0 }Lg/ml). Higher intravenous dosages of pethidine than those used in this study have been reported. McDowell and Whitlow ( 1977 ) have administered 200 mg over twenty minutes to patients for sedation during surgery. Side effects from pethidine infused at ten times the rate of the present study were reported to be low, The clinical pharmacology of norpe~hidine in man is unknown although it has been reported to be twice as convulsive and half as analgesic as pethidine in the rat and monkey (Miller and Anderson 1954, Deneau and Nakai 1960) . No deleterious effects were observed at concentrations up to 0.6 }Lg/ml in the present study.
Patient acceptance of the technique was favourable. Most of the unpleasant effects associated with intravenous and intramuscular administration of narcotics were avoided. Although blood concentrations were maintained sufficiently high to completely relieve severe pain in all patients on the second day, most remained alert and were able to read. Many patients requested infusions in the event of future surgery. Patients with previous experience of surgical pain rated the relief provided by the infusion far superior to intermittent intramuscular injections while those having rheir first operation considered the pain relief to b~ excellent. There was no interference with routine nursing care nor post-operative medical management although patients were partially restricted in their movements throughout the study period because of a cannula in each arm. These restrictions would not apply during routine use when blood sampling would not be required and if a portable infusion pump was used.
The success of this infusion regimen in controlling post-operative pain was dramatic and without precedent. A similar dose rate administered via intermittent intramuscular injections resulted in variable pain control (Austin, Stapleton and Mather 1978, in preparation) suggesting that inadequate blood concentrations are responsible for poor control of post-operative pain. Present results suggest that a therapeutic concentration could be maintained after a 25-30% reduction in the infusion rate of pethidine.
The technique has three important advantages: analgesia is continuous, side effects are minimal and repeated intramuscular injections with their concomitant discomfort and fluctuating blood concentrations are avoided. It is simple to perform and is therapeutically efficacious. We conclude that the continuous intravenous infusion of pethidine may offer a significant advance in pain management.
